Marvel Biosciences Corp. (TSXV:MRVL)
Canada · Delayed Price · Currency is CAD 0.1200
0.00 (0.00%)
Oct 30, 2026, 9:43 AM EDT
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of CAD 8.86 million as of October 30, 2026. It is the 43,739th most valuable company in the world and the 1,643rd biggest in Canada. Its market cap has decreased by 29.88% in one year.
Market Cap
8.86M
Enterprise Value
9.82M
Revenue
n/a
Global Rank
Country Rank
#1,643 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 8.86M, a decrease of -30.32%. That is a compound annual growth rate of -6.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 8.86M | 13.09% |
| Dec 31, 2025 | 7.83M | 2.85% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rapid Dose Therapeutics | 13.78M |
| Alzai Health | 12.96M |
| PreveCeutical Medical | 12.76M |
| Hemostemix | 12.69M |
| Britannia Life Sciences | 11.52M |
| COSCIENS Biopharma | 8.78M |
| Rakovina Therapeutics | 7.80M |
| Glow Lifetech | 7.70M |